Growth & profitability
- Revenue has declined 0.3% per year over the past 5 years.
Financial health
- Total debt has grown slower than revenue (-61.8% vs -0.3% per year).
14 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | — | -$5M | — | — | — | — | $4M |
| 2024 | $8M | -$10M | 0.0% | -125.1% | -$11M | — | $10M |
| 2023 | $7M | -$14M | 0.0% | -202.0% | -$17M | — | $19M |
| 2022 | $6M | -$19M | 0.0% | -312.1% | -$19M | — | $36M |
| 2021 | $5M | -$20M | 0.0% | -390.2% | -$20M | — | $54M |
| 2020 | $13M | -$19M | 0.0% | -78.1% | -$13M | — | $32M |
| 2019 | $8M | -$21M | 0.0% | -261.6% | $3M | — | $23M |
| 2018 | — | -$21M | — | — | -$17M | — | $3M |
| 2017 | — | -$18M | — | — | -$15M | — | $4M |
| 2016 | — | -$28M | — | — | — | $6M | $4M |
| 2015 | — | -$26M | — | — | — | $7M | $19M |
| 2015 | — | -$7M | — | — | — | — | $3M |
| 2014 | — | -$24M | — | — | — | $40M | $451000 |
| 2014 | — | -$3M | — | — | — | — | $16M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | — | -$1M | — | — | — | — | $3M |
| Dec '25 | — | -$928000 | — | — | — | — | $4M |
| Sep '25 | — | -$877000 | — | — | — | — | $5M |
| Jun '25 | — | -$2M | — | — | — | — | $6M |
| Mar '25 | — | -$2M | — | — | — | — | $8M |
| Dec '24 | $3000 | -$2M | 0.0% | -65066.7% | -$1M | — | $10M |
| Sep '24 | $366000 | -$3M | 0.0% | -726.0% | -$3M | — | $11M |
| Jun '24 | $2M | -$6M | 0.0% | -380.2% | -$4M | — | $12M |
| Mar '24 | $6M | $825000 | 0.0% | 12.7% | -$3M | — | $16M |
| Dec '23 | $2M | -$2M | 0.0% | -101.0% | -$2M | — | $19M |
| Sep '23 | $2M | -$4M | 0.0% | -224.7% | -$4M | — | $21M |
| Jun '23 | $2M | -$4M | 0.0% | -216.4% | — | — | $26M |
| Mar '23 | $1M | -$4M | 0.0% | -305.9% | — | — | $31M |
| Dec '22 | $2M | -$4M | 0.0% | -253.2% | -$5M | — | $36M |
| Sep '22 | $2M | -$5M | 0.0% | -272.4% | -$4M | — | $41M |
| Jun '22 | $1M | -$5M | 0.0% | -342.5% | -$5M | — | $43M |
| Mar '22 | $1M | -$5M | 0.0% | -427.8% | -$6M | — | $48M |
| Dec '21 | $456000 | -$4M | 0.0% | -886.6% | -$4M | — | $54M |
| Sep '21 | $1M | -$8M | 0.0% | -766.1% | -$3M | — | $53M |
| Jun '21 | $2M | -$4M | 0.0% | -170.8% | — | — | $57M |
How the market has priced PULM against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Pulmatrix, Inc.'s revenue has declined 0.3% per year. These are computed facts, not advice.
As of FY2025, Pulmatrix, Inc. reported — of total debt against $4M of cash.
In FY2025, gross margin was —, operating margin —, and net margin —.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.